EyePoint (EYPT) Share-based Compensation Growth (5y) (2015 - 2026)
EyePoint (EYPT) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.04% |
| Dec 31, 2025 | -16.07% |
| Sep 30, 2025 | -15.50% |
| Jun 30, 2025 | 54.30% |
| Mar 31, 2025 | -4.89% |
| Dec 31, 2024 | 32.36% |
| Sep 30, 2024 | 251.14% |
| Jun 30, 2024 | -8.03% |
| Mar 31, 2024 | 59.30% |
| Dec 31, 2023 | -39.70% |
| Sep 30, 2023 | 5.22% |
| Jun 30, 2023 | 4.76% |
| Mar 31, 2023 | 47.09% |
| Dec 31, 2022 | 40.86% |
| Sep 30, 2022 | 36.26% |
| Jun 30, 2022 | 43.43% |
| Mar 31, 2022 | -19.02% |
| Dec 31, 2021 | -58.29% |
| Sep 30, 2021 | -14.95% |
| Jun 30, 2021 | -15.09% |